Lung Cancer, Protection Against
1 clinical trials · Condition
◉ Watch Lung Cancer, Protection Against
| Record | Firm | Date |
|---|---|---|
| Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers (NCT03598309) | H. Lee Moffitt Cancer Center and Research Institute | 2019-06-05 |
Track Lung Cancer, Protection Against automatically
Every clearance here is in the API, with alerts when new ones post.